Description
NSE announces listing of additional equity shares issued under ESOP/ESOS schemes for 18 companies effective September 3, 2025
Summary
The National Stock Exchange has notified the listing of additional equity shares issued under Employee Stock Option Plans (ESOP) and Employee Stock Ownership Schemes (ESOS) for 18 companies. These securities will be admitted to dealings on the NSE Capital Market segment effective September 3, 2025, with standard market lot size of 1 share for all listed securities.
Key Points
- 18 companies issuing additional shares under ESOP/ESOS schemes
- All securities to be listed on September 3, 2025
- Market lot size standardized at 1 share for all securities
- All shares are pari passu with existing equity shares
- Lock-in period applicable only for Bliss GVS Pharma shares (until January 28, 2026)
Regulatory Changes
No regulatory changes announced. This circular follows standard procedures under Regulation 3.1.1 and Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A.
Compliance Requirements
- Companies must ensure proper identification of securities using designated security codes
- Trading must be conducted in specified lot sizes (1 share for all securities)
- Members must note the effective date of September 3, 2025 for trading commencement
Important Dates
- Circular Date: September 2, 2025
- Effective Date: September 3, 2025
- Lock-in Expiry (Bliss GVS Pharma only): January 28, 2026
Impact Assessment
Minimal market impact expected as these are routine ESOP/ESOS allotments representing small additions to existing share capital. The shares are pari passu with existing equity, ensuring no dilution of rights for current shareholders. The standardized lot size of 1 share ensures maximum liquidity and accessibility for all market participants.
Impact Justification
Routine ESOP/ESOS allotments with minimal market impact as shares are already trading